WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000028064) VANCORESMYCIN, A PROCESS FOR ITS PRODUCTION AND ITS USE AS A PHARMACEUTICAL
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/028064    International Application No.:    PCT/EP1999/008415
Publication Date: 18.05.2000 International Filing Date: 04.11.1999
Chapter 2 Demand Filed:    02.06.2000    
IPC:
C07H 15/04 (2006.01), C12P 17/16 (2006.01), C12P 19/44 (2006.01)
Applicants: AVENTIS PHARMA DEUTSCHLAND GMBH [DE/DE]; Brüningstrasse 50 D-65929 Frankfurt am Main (DE)
Inventors: RAMAKRISHNA, Nirogi, Venkata, Satya; (IN).
BHAT, Ravi, Gayanan; (IN).
SREEKUMAR, Eyyammadichiyil, Sankaranarayanan; (IN).
VIJAYAKUMAR, Erra, Koteswara, Satya; (IN).
NAKER, Shantilal, Dayaram; (IN).
OAK, Uttara, Vinayak; (IN).
TANPURE, Rajendra, Prakash; (IN).
HOPMANN, Cordula; (DE).
KURZ, Michael; (DE).
WINK, Joachim; (DE).
SEIBERT, Gerhard; (DE).
LE BELLER, Dominique; (FR).
ASZODI, Jozsef; (FR)
Priority Data:
98121299.6 09.11.1998 EP
Title (EN) VANCORESMYCIN, A PROCESS FOR ITS PRODUCTION AND ITS USE AS A PHARMACEUTICAL
(FR) VANCORESMYCINE, SON PROCEDE D'ELABORATION, ET SON UTILISATION COMME PRODUIT PHARMACEUTIQUE
Abstract: front page image
(EN)The present invention relates to a compound named Vancoresmycin which is obtainable by cultivation of the microorganism HIL-006734 (DSM 12216), and to its pharmaceutically acceptable salts. The present invention further relates to a process for the production of Vancoresmycin, to the microorganism HIL-00673 (DSM 12216), to the use of Vancoresmycin and its pharmaceutically acceptable salts as pharmaceuticals, in particular to their use as antibiotics, and to pharmaceutical compositions comprising Vancoresmycin or a pharmaceutically acceptable salt thereof.
(FR)La présente invention concerne un composé ci-après dénommé Vancoresmycine, que l'on peut obtenir en cultivant le micro-organisme HIL-006734 (DSM 12216). L'invention concerne également les sels pharmaceutiquement acceptables de ce composé Vancoresmycine, ainsi qu'un procédé d'élaboration de celui-ci. Cette invention concerne en outre ledit micro-organisme HIL-006734 (DSM 12216), l'utilisation de Vancoresmycine et de ses sels pharmaceutiquement acceptables comme produits pharmaceutiques, et plus particulièrement leur utilisation comme antibiotiques. Cette invention concerne enfin des compositions pharmaceutiques renfermant ledit composé Vancoresmycine ou un sel pharmaceutiquement acceptable de celui-ci.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)